Search Results 321-330 of 17438 for Osteoporosis

1. Overview - Renal Disease Laboratory - Mayo Clinic Research

   Kumar's work is relevant to the pathogenesis and treatment of bone disease seen in patients with renal failure, osteoporosis and hypophosphatemia. Read more ...

2. Mayo Clinic releases book on whole-body wellness, complementary techniques

   Mayo Clinic: The Integrative Guide to Good Health covers home solutions to help manage common issues, such as high blood pressure, osteoporosis, hives and ...

3. Vikas Majithia, M.B.B.S., M.P.H.

   Spondyloarthritides · Axial Spondyloarthritis · Psoriatic arthritis · Systemic Lupus erythematosus · Osteoporosis · Inflammatory Eye Diseases · Rheumatoid Arthritis ...

4. Betamethasone sodium phosphate and betamethasone acetate (injection route) - Mayo Clinic

   Osteoporosis (weak bones) or; Pheochromocytoma (adrenal tumor) or; Stomach or ... This medicine might cause thinning of the bones (osteoporosis) or slow growth in ...

5. Health Topics - Mayo Clinic News Network

   Mayo Clinic Minute: What women should know about osteoporosis risk. Alex Osiadacz. May 9, 2022. Mayo Clinic Q & A. Mayo Clinic Q and A: Putting your best foot ...

6. Incidentally discovered adrenal masses and subclinical Cushing syndrome - Mayo Clinic

   ... osteoporosis and fractures, diabetes mellitus, dyslipidemia, and hypertension." Biochemical diagnosis of cortisol excess Biochemical diagnosis Enlarge image.

7. Alex Osiadacz | Mayo Clinic News Network - Page 6 of 8

   Mayo Clinic Minute: What women should know about osteoporosis risk. Bones are living organisms that build and break down, but when the body loses more bone ...

8. Women's Wellness: Reduce health risks from early removal of ovaries - Mayo Clinic News Network

   ... osteoporosis. Removing both ovaries — a procedure called bilateral oophorectomy — triggers menopause in women who have not already gone through it. Along ...

9. A Study to Evaluate Cellular Senescence with Senolytics to Improve Skeletal Health in Older Humans - Mayo Clinic

   ... osteoporosis drug through her primary care physician or continue in the study and defer osteoporosis drug treatment for the duration of the study (20 weeks).

10. Ravinder J. Singh, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Diagnostic Endocrinology for Cushing's, diabetes, hypothyroidism, osteoporosis, acromegaly, and Congenital Adrenal Hyperplasia. Conversion of steroids ...